AUVI-Q 0.3 MG AUTO-INJECTOR
FDA nonproprietary name: epinephrine
For 1 unit (EA)
Pharmacies pay
$309.38 filed
1 × $309.37573 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$300.57 filed
1 × $300.57204 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.97× estimated
Medicare paid about what pharmacies pay.
Part D averages every strength and form sold under “Auvi-Q” / “Epinephrine” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-07-01 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$360.79 estimated
$309.38 + $46.41 (15%) + $5.00 fee per fill = $360.79
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-07-01 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
AUVI-Q 0.3 MG AUTO-INJECTOR is how the CMS NADAC file names this product. The FDA NDC Directory lists it as epinephrine, under the trade name “Auvi-Q”.
FDA gives its dosage form as injection, solution and its route as intramuscular.
The labeler, the company named on the label, is kaleo, Inc.
FDA lists it under 3 Established Pharmacologic Classes: alpha-Adrenergic Agonist, beta-Adrenergic Agonist and Catecholamine.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes); the FDA directory lists 1 of them.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $309.38 for 1 unit (EA) (1 × $309.37573 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-07-01. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 2, the latest survey was within 2% of the current NADAC, so the NADAC was carried forward from the previous file.
The NADAC of all 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-07-01. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
All 2 NDCs
- 60842-0023-01 · not listed as a package in the FDA directory · $309.37573 per EA · eff. 2026-07-01 filed carried forward
- 60842-0023-02 · kaleo, Inc · $309.37573 per EA · eff. 2026-07-01 filed carried forward
Other strengths, forms and brands
8 other products in the NADAC file share the FDA nonproprietary name epinephrine with AUVI-Q 0.3 MG AUTO-INJECTOR.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ADRENALIN 1 MG/ML VIAL | $7.79554 per ML filed | $13.74495 per ML filed |
| AUVI-Q 0.1 MG AUTO-INJECTOR | $309.55227 per EA filed | $300.57204 per EA filed |
| AUVI-Q 0.15 MG AUTO-INJECTOR | $309.85103 per EA filed | $300.57204 per EA filed |
| AUVI-Q 0.3 MG AUTO-INJECTOR this page | $309.37573 per EA filed | $300.57204 per EA filed |
| EPINEPHRINE 0.15 MG AUTO-INJCT | $117.96603 to $141.88177 per EA filed | $99.62948 per EA filed |
| EPINEPHRINE 0.3 MG AUTO-INJECT | $111.99764 to $141.27567 per EA filed | $99.62948 per EA filed |
| EPINEPHRINE 1 MG/10 ML LUERJET | $1.23804 per ML filed | We don’t know yet |
| NEFFY 1 MG/0.1 ML NASAL SPRAY | $360.13761 per EA filed | $340.89238 per EA filed |
| NEFFY 2 MG/0.1 ML NASAL SPRAY | $359.49229 per EA filed | $340.89238 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-10-28, 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $309.37573 per EA filed.
Of the 59 other products in FDA’s alpha-Adrenergic Agonist class priced per EA, 4 have a higher middle NADAC price and 55 a lower one. The one in the middle is FEXOFENADINE-PSE ER 60-120 TAB, at $0.48321 per EA filed (eff. 2026-09-23).
Of the 6 other products in FDA’s beta-Adrenergic Agonist class priced per EA, 4 have a higher middle NADAC price and 2 a lower one. The one in the middle is AUVI-Q 0.1 MG AUTO-INJECTOR, at $309.55227 per EA filed (eff. 2026-07-01).
Of the 6 other products in FDA’s Catecholamine class priced per EA, 4 have a higher middle NADAC price and 2 a lower one. The one in the middle is AUVI-Q 0.1 MG AUTO-INJECTOR, at $309.55227 per EA filed (eff. 2026-07-01).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $300.57 for 1 unit (EA), at an average of $300.57204 per EA in 2024 (2024-01-01 to 2024-12-31) for “Auvi-Q” and “Epinephrine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 1,035 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for AUVI-Q 0.3 MG AUTO-INJECTOR labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Auvi-Q / Epinephrine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
- Why does this page start at 1 unit (EA)?
- NADAC prices this product per EA, and the FDA NDC Directory lists 1 of its 2 NDCs (it does not list the other one) as dosage form “INJECTION, SOLUTION” with route “INTRAMUSCULAR”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.
Related pages
Its pharmacologic classes
Related in the same class
- LIDOCAINE 1%-EPI 1:100,000
- BRIMONIDINE 0.2% EYE DROP
- MIDODRINE HCL 10 MG TABLET
- BRIMONIDINE-TIMOLOL 0.2%-0.5%
- COMBIGAN 0.2%-0.5% EYE DROPS